Lactose (India) Limited (BOM:524202)

Market Cap	1.46B +7.7%
Revenue (ttm)	1.63B +40.3%
Net Income	60.63M +17.4%
EPS	4.68 +15.3%
Shares Out	12.59M
PE Ratio	24.79
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,614
Open	120.95
Previous Close	121.15
Day's Range	115.00 - 120.95
52-Week Range	76.01 - 136.70
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	May 20, 2026

About Lactose (India)

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as w...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 140
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524202

Financial Performance

In fiscal year 2026, Lactose (India)'s revenue was 1.63 billion, an increase of 40.28% compared to the previous year's 1.16 billion. Earnings were 60.63 million, an increase of 17.43%.